Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1993-06-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00065A003PMID 8515420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low molecular weight, non-peptide fibrinogen receptor antagonists.

  1992cited by this paper
• Cyclic RGD peptide analogues as antiplatelet antithrombotics.

  1992cited by this paper
• Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.

  1992cited by this paper
• Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.

  1992cited by this paper
• Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor.

  1992cited by this paper
• Relative differences in the binding free energies of human immunodeficiency virus 1 protease inhibitors: a thermodynamic cycle-perturbation approach.

  1991cited by this paper
• A discrete sequence in a platelet integrin is involved in ligand recognition

  1991cited by this paper
• Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.

  1991cited by this paper
• Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa.

  1989cited by this paper
• Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis.

  1989cited by this paper
• Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.

  1988cited by this paper
• The platelet membrane glycoprotein IIb-IIIa complex.

  1988cited by this paper
• Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets.

  1987cited by this paper
• Experimental Studies on the Antithrombotic Action of a Highly Effective Synthetic Thrombin Inhibitor

  1986cited by this paper
• Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin.

  1983cited by this paper
• Refinement of the structure of carp muscle calcium-binding parvalbumin by model building and difference Fourier analysis.

  1976cited by this paper

• Mimetics of the Arg-Gly-Asp Sequence: Synthesis and Studies of the Antiaggregative Properties

  2021cites this paper
• Guanidinate, Amidinate, and Formamidinate Ligands

  2021cites this paper
• Non‐peptide‐based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies

  2018cites this paper
• Discovery of Aporphine Analogues as Potential Antiplatelet and Antioxidant Agents: Design, Synthesis, Structure–Activity Relationships, Biological Evaluations, and in silico Molecular Docking Studies

  2018cites this paper
• In Vitro Antiviral Activity of New Oxazoline Derivatives as Potent Poliovirus Inhibitors.

  2018cites this paper
• Ugi three-component reaction of alcohols, amines and isocyanides: A new approach to the synthesis of cyclic amidines

  2017cites this paper
• Synthesis of 4-(ω-X-alkyl)benzonitriles (X = 1,3-dioxan-2-yl, CN, CO2Et) by the reaction of terephthalonitrile dianion with ω-X-alkyl bromides in liquid ammonia

  2016cites this paper
• Biologically active compounds based on the privileged 2-imidazoline scaffold: The world beyond adrenergic/imidazoline receptor modulators.

  2015cites this paper
• Progress in the research of GPIIb/IIIa antagonists.

  2015cites this paper
• The synthesis of 4,7-disubstituted-2H-benzo[b][1,4]-oxazin-3(4H)-ones using Smiles rearrangement and their in vitro evaluation as platelet aggregation inhibitors.

  2014cites this paper
• Synthesis of α-amino amidines through molecular iodine-catalyzed three-component coupling of isocyanides, aldehydes and amines

  2014cites this paper
• Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy

  2014cites this paper
• and ADP receptors 3 β IIb α human platelets requires coordinated signaling through integrin induced thromboxane A2generation in - Adenosine diphosphate (ADP)

  2013cites this paper
• receptor-mediated platelet functional responses Role of G protein-gated inwardly-rectifying potassium channels in P2Y12

  2013cites this paper
• Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring.

  2013cites this paper
• Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats

  2012cites this paper
• Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.

  2012cites this paper
• Tripeptide motifs in biology: targets for peptidomimetic design.

  2011cites this paper
• Copper-catalyzed multicomponent reaction: facile access to novel phosphorus amidines.

  2008cites this paper
• Synthesis and Conformational Study of N-Methylated Cyclic Peptides

  2008cites this paper
• New amidines from intramolecular cyclization in triflic acid of nitroketene aminals with a tethered phenyl ring

  2007cites this paper
• Heck arylations of pent-4-enoates or allylmalonate using a palladium/tetraphosphine catalyst

  2007cites this paper
• Peptide Mimetic Design with the Aid of Computational Chemistry

  2007cites this paper
• 2.15 – Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

  2007cites this paper
• zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München

  2006cites this paper
• The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogues

  2006cites this paper
• Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one scaffold. A systematic study.

  2005cites this paper
• Amidines and N -Substituted Amidines

  2005cites this paper
• Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.

  2004cites this paper
• Solid-phase synthesis of amidines by the reduction of amidoximes

  2004cites this paper
• αv Integrins mediate adhesion and migration of breast carcinoma cell lines

  2004cites this paper
• Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.

  2004cites this paper
• Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.

  2004cites this paper
• Diverse actions of neonicotinoids on chicken α7, α4β2 and Drosophila–chicken SADβ2 and ALSβ2 hybrid nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes

  2003cites this paper
• Nucleo amino acids as arginine mimetics in cyclic peptides

  2003cites this paper
• Diverse actions of neonicotinoids on chicken alpha7, alpha4beta2 and Drosophila-chicken SADbeta2 and ALSbeta2 hybrid nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.

  2003cites this paper
• Dynamic regulation of microtubule coils in ADP-induced platelet shape change by p160ROCK (Rho-kinase)

  2003cites this paper
• Synthesis of target-specific radiolabeled peptides for diagnostic imaging.

  2003cites this paper
• A new catalytic cross-coupling approach for the synthesis of protected aryl and heteroaryl amidines.

  2002cites this paper
• New RGD amphiphilic cyclic peptide and new RGD-mimetic constrained diketopiperazines

  2002cites this paper
• Characterization of a Ligand-attenuated Binding Site on Glycoprotein IIb/IIIa

  2002cites this paper
• Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.

  2002cites this paper
• Adenosine diphosphate (ADP)–induced thromboxane A2generation in human platelets requires coordinated signaling through integrin αIIbβ3 and ADP receptors

  2002cites this paper
• Binding mechanism of RGD and its mimetics to receptor GPIIb/IIIa. A theoretical study

  2001cites this paper
• Potentiation of Thromboxane A2-induced Platelet Secretion by Gi Signaling through the Phosphoinositide-3 Kinase Pathway

  2001cites this paper
• Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: synthesis and pharmacological evaluation of 2-oxopiperazine derivatives.

  2001cites this paper
• Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold.

  2001cites this paper
• Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agent.

  2001cites this paper
• Concise Synthesis of Sibrafiban and Lamifiban, Two Non‐Peptide Fibrinogen Receptor (GPIIb/IIIa) Antagonists

  2001cites this paper
• Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.

  2000cites this paper
• Structural analysis of the KGD sequence loop of barbourin, an αIIbβ3-specific disintegrin

  2000cites this paper
• Glycoprotein IIb/IIIa Antagonists Induce Apoptosis in Rat Cardiomyocytes by Caspase-3 Activation*

  2000cites this paper
• Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides.

  2000cites this paper
• Fused bicyclic Gly-Asp beta-turn mimics with potent affinity for GPIIb-IIIa. Exploration of the arginine isostere.

  2000cites this paper
• Preferred conformations of a linear RGD tripeptide.

  2000cites this paper
• Ligands to the integrin receptor αvβ3

  2000cites this paper
• Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.

  1999cites this paper
• Fused bicyclic Gly-Asp beta-turn mimics with specific affinity for GPIIb-IIIa.

  1999cites this paper
• Platelet Shape Change Is Mediated by both Calcium-dependent and -independent Signaling Pathways

  1999cites this paper
• Structure-activity relationships of RGD mimetics as fibrinogen-receptor antagonists.

  1999cites this paper
• The twists and turns of beta-peptides.

  1999cites this paper
• Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists.

  1999cites this paper
• Preparation and pharmacological evaluation of novel glycoprotein (Gp) IIb/IIIa antagonists. 1. The selection of naphthalene derivatives.

  1999cites this paper
• Fibrinogen receptor antagonists: design and clinical applications.

  1999cites this paper
• Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.

  1998cites this paper
• Long-term administration of glycoprotein IIb/IIIa

  1998cites this paper
• Discovery and pharmacological evaluation of new platelet glycoprotein gpIIb/IIIa antagonists.

  1998cites this paper
• A Comparison of the Bioconversion Rates and the Caco-2 Cell Permeation Characteristics of Coumarin-Based Cyclic Prodrugs and Methylester-Based Linear Prodrugs of RGD Peptidomimetics

  1998cites this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cites this paper
• Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.

  1998cites this paper
• Preparation and biological activity of novel tricyclic GPIIb/IIIa antagonists.

  1998cites this paper
• A Constrained Diketopiperazine as a New Scaffold for the Synthesis of Peptidomimetics

  1998cites this paper
• Orally Active Isoxazoline GPIIb/IIIa Antagonists

  1998cites this paper
• Long-term administration of glycoprotein IIb/IIIa antagonists.

  1998cites this paper
• Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.

  1997cites this paper
• Design, synthesis, and in vitro activities of benzamide-core glycoprotein IIb/IIIa antagonists: 2,3-diaminopropionic acid derivatives as surrogates of aspartic acid.

  1997cites this paper
• Nonpeptide glycoprotein IIB/IIIA inhibitors: 18. Indole alpha-sulfonamide acids are potent inhibitors of platelet aggregation

  1997cites this paper
• Fibrinogen receptor (GPIIb-IIIa) antagonists derived from 5,6-bicyclic templates. Amidinoindoles, amidinoindazoles, and amidinobenzofurans containing the N-alpha-sulfonamide carboxylic acid function as potent platelet aggregation inhibitors.

  1997cites this paper
• Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists.

  1997cites this paper
• Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists.

  1997cites this paper
• Prodrug strategies based on intramolecular cyclization reactions.

  1997cites this paper
• Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide.

  1997influential citation
• New antiplatelet drugs

  1997cites this paper
• 99mTc labeling of highly potent small peptides.

  1997cites this paper
• Platelet glycoprotein IIb–IIIa receptor (GPIIb–IIIa) antagonists derived from amidinoindoles

  1996cites this paper
• Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.

  1996cites this paper
• Discovery of an orally active non-peptide fibrinogen receptor antagonist.

  1996cites this paper
• Labeling cyclic glycoprotein IIb/IIIa receptor antagonists with 99mTc by the preformed chelate approach: effects of chelators on properties of [99mTc]chelator-peptide conjugates.

  1996cites this paper
• Design, synthesis and in vitro activities of a series of benzimidazole/benzoxazole glycoprotein IIb/IIIa inhibitors

  1996cites this paper
• Nonpeptide glycoprotein IIB/IIIA inhibitors. 12. Potent and orally active centrally constrained thieno[2,3-c]pyridones

  1996cites this paper
• Design, synthesis, and evaluation of fibrinogen inhibitors, ω-(p-amidinophenoxy) alkanoylaspartic acid derivatives

  1996cites this paper
• An Allosteric Ca2+ Binding Site on the β3-Integrins That Regulates the Dissociation Rate for RGD Ligands*

  1996cites this paper
• Isomerization of the Xaa-Pro peptide bond induced by ionic interactions of arginine.

  1996cites this paper
• A versatile synthesis of amidines from nitriles via amidoximes

  1996cites this paper
• The Amino-terminal One-third of Defines the Ligand Recognition Specificity of Integrin (*)

  1996cites this paper
• ADP receptors on platelets and ADP-selective antiaggregating agents.

  1996cites this paper
• Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists.

  1995cites this paper
• A novel series of orally active antiplatelet agents.

  1995cites this paper
• Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.

  1995cites this paper
• Antithrombotic Effect of a New Glycoprotein IIb/IIIa Antagonist, SC-52012A: Studies in two Guinea-pig Thrombosis Models.

  1995cites this paper